Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples